← All diseases
Cancer
Melanoma (metastatic)
Want to be notified when there is new research on Melanoma (metastatic)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Melanoma (metastatic). View what Premium costs.
Publications and studies (1866)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma Patient. (2023/12/15) ♡
- Cutaneous type IV hypersensitivity reaction following tebentafusp treatment for uveal melanoma. (2023/12/15) ♡
- Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study. (2023/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Focal reactive nodular gliosis: an extremely rare retinal astrocytic tumor. (2023/12/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case Report of Primary Malignant Melanoma of the Gallbladder with Multiple Metastases. (2023/12/12) ♡
- Pediatric Atypical Melanocytic Proliferations: Single-Site Retrospective Cohort Assessment of Treatment and Long-Term Follow-Up. (2023/12/12) ♡
- CD8-Lymphocytic Phenotype Significance in Primary Multiple and Familial Melanoma with Various CDKN2A Mutational Status. (2023/12/12) ♡
- Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data. (2023/12/09) ♡
- T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis. (2023/12/08) ♡
- A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in Japan. (2023/12/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Comparative Study of Metastasis Suppression Effects of Extracellular Vesicles Derived from Anaplastic Cell Lines, Nanog-Overexpressing Melanoma, and Induced Pluripotent Stem Cells. (2023/12/06) ♡
- Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis. (2023/12/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Suspected Primary Intracranial Melanoma with Widespread Distant Metastases in a Cat. (2023/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dabrafenib Therapy and BRAF Genotype. (2023/12/04) ♡
- Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas. (2023/12/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Long-term metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon. (2023/12/04) ♡
- Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab. (2023/12/02) ♡
- Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity. (2023/12/01) ♡
- Three-dimensional reconstruction of interstitial extracellular vesicles in human liver as determined by electron tomography. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acantholytic Squamous Cell Carcinoma: a Diagnostic Pitfall on Cytology. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Merkel Cell Carcinoma of Unknown Primary Origin. (2023/12/01) ♡
- Multi-nodal basin drainage in lower limb melanoma. (2023/11/24) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. c-Met(+) Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models. (2023/11/23) ♡
- Ascomylactam C Induces an Immunogenic Cell Death Signature via Mitochondria-Associated ER Stress in Lung Cancer and Melanoma. (2023/11/21) ♡
- The Blocking of Drug Resistance Channels by Selected Hydrophobic Statins in Chemoresistance Human Melanoma. (2023/11/21) ♡
- Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. (2023/11/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap. (2023/11/18) ♡
- Silencing of Dicer enhances dacarbazine resistance in melanoma cells by inhibiting ADSL expression. (2023/11/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Gastric and colonic metastases of malignant melanoma diagnosed during endoscopic evaluation of symptomatic anemia presenting as angina: a case report. (2023/11/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. (2023/10/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report. (2023/10/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Right upper lobectomy after immunotherapy for primary malignant melanoma of the lung: a case report and literature review. (2023/10/19) ♡
- 8q Gain Has No Additional Predictive Value in SF3B1(MUT) Uveal Melanoma but Is Predictive for a Worse Prognosis in Patients with BAP1(MUT) Uveal Melanoma. (2023/10/16) ♡
- Unexpected and Rare Sites of Metastasis in Oncologic Patients. (2023/10/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab. (2023/10/04) ♡
- Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through ER stress-dependent apoptosis based on the network pharmacology. (2023/10/01) ♡
- Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors. (2023/10/01) ♡
- Blebs and former blebs: From surface protrusions to extracellular vesicles in cancer signalling, anoikis resistance and beyond. (2023/10/01) ♡
- The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors. (2023/09/29) ♡
- Ultrasound Verification of Plaque Brachytherapy Placement in Patients Treated for Primary Uveal Melanoma: A Single-Center Experience. (2023/08/01) ♡
- A Theranostic Approach to Imaging and Treating Melanoma with (203)Pb/(212)Pb-Labeled Antibody Targeting Melanin. (2023/07/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Merkel Cell Carcinoma of the Left Cheek With Testicular Metastasis: An Uncommon Occurrence. (2023/07/20) ♡
- Nonsquamous Malignancies of Vagina and Vulva: 23-Year Experience at a Tertiary Center in the United Kingdom. (2023/07/01) ♡
- Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors. (2023/07/01) ♡
- Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth. (2023/06/30) ♡
- In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy. (2023/06/13) ♡
- A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma. (2023/06/09) ♡
- Analysis of the Gut Microbiome and Dietary Habits in Metastatic Melanoma Patients with a Complete and Sustained Response to Immunotherapy. (2023/06/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.